Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

Female sex, antidepressant use, and type of health insurance significantly influence semaglutide initiation. (HealthDay News) — Sociodemographic, health care, and clinical factors are associated with ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...

The team categorized pediatric obesity treatment response, based on changes in body mass index standard deviation score, as ...